Cargando…

Marked improvement of Churg–Strauss syndrome neuropathy by intravenous immunoglobulin and cyclophosphamide

A 42-year-old Japanese man developed Churg–Strauss syndrome 7 years after being diagnosed with chronic eosinophilic pneumonia. Prominent eosinophilia, subcutaneous nodules, and neuropathy in the left leg were seen. A pathological diagnosis of necrotizing vasculitis was determined by a biopsy of a su...

Descripción completa

Detalles Bibliográficos
Autores principales: Umeda, Akira, Yamane, Tateki, Takeuchi, Jin, Imai, Yasuo, Suzuki, Keisuke, Yumura, Wako
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184514/
https://www.ncbi.nlm.nih.gov/pubmed/25473575
http://dx.doi.org/10.1002/rcr2.56
_version_ 1782337854263787520
author Umeda, Akira
Yamane, Tateki
Takeuchi, Jin
Imai, Yasuo
Suzuki, Keisuke
Yumura, Wako
author_facet Umeda, Akira
Yamane, Tateki
Takeuchi, Jin
Imai, Yasuo
Suzuki, Keisuke
Yumura, Wako
author_sort Umeda, Akira
collection PubMed
description A 42-year-old Japanese man developed Churg–Strauss syndrome 7 years after being diagnosed with chronic eosinophilic pneumonia. Prominent eosinophilia, subcutaneous nodules, and neuropathy in the left leg were seen. A pathological diagnosis of necrotizing vasculitis was determined by a biopsy of a subcutaneous nodule. The leg pain was severe and there was prominent atrophy of the thigh and calf, but the muscle weakness was mild. Serum anti-myeloperoxidase anti-neutrophil cytoplasmic antibody was positive. Because the initial treatment with an intravenous methylprednisolone pulse at 1 g/day for 3 days was not sufficient, a onetime treatment with intravenous cyclophosphamide at 15 mg/kg and intravenous immunoglobulin therapy (IVIG) at 400 mg/kg/day for 5 days were administered. Peripheral eosinophilia improved and the leg pain significantly improved. IVIG was repeated 1 month later and symptoms gradually improved further. The early diagnosis of Churg–Strauss syndrome and the early initiation of IVIG with cyclophosphamide were thought to be important.
format Online
Article
Text
id pubmed-4184514
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BlackWell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-41845142014-12-03 Marked improvement of Churg–Strauss syndrome neuropathy by intravenous immunoglobulin and cyclophosphamide Umeda, Akira Yamane, Tateki Takeuchi, Jin Imai, Yasuo Suzuki, Keisuke Yumura, Wako Respirol Case Rep Case Reports A 42-year-old Japanese man developed Churg–Strauss syndrome 7 years after being diagnosed with chronic eosinophilic pneumonia. Prominent eosinophilia, subcutaneous nodules, and neuropathy in the left leg were seen. A pathological diagnosis of necrotizing vasculitis was determined by a biopsy of a subcutaneous nodule. The leg pain was severe and there was prominent atrophy of the thigh and calf, but the muscle weakness was mild. Serum anti-myeloperoxidase anti-neutrophil cytoplasmic antibody was positive. Because the initial treatment with an intravenous methylprednisolone pulse at 1 g/day for 3 days was not sufficient, a onetime treatment with intravenous cyclophosphamide at 15 mg/kg and intravenous immunoglobulin therapy (IVIG) at 400 mg/kg/day for 5 days were administered. Peripheral eosinophilia improved and the leg pain significantly improved. IVIG was repeated 1 month later and symptoms gradually improved further. The early diagnosis of Churg–Strauss syndrome and the early initiation of IVIG with cyclophosphamide were thought to be important. BlackWell Publishing Ltd 2014-06 2014-04-14 /pmc/articles/PMC4184514/ /pubmed/25473575 http://dx.doi.org/10.1002/rcr2.56 Text en © 2014 The Authors. Respirology Case Reports published by John Wiley & Sons Ltd on behalf of The Asian Pacific Society of Respirology. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Umeda, Akira
Yamane, Tateki
Takeuchi, Jin
Imai, Yasuo
Suzuki, Keisuke
Yumura, Wako
Marked improvement of Churg–Strauss syndrome neuropathy by intravenous immunoglobulin and cyclophosphamide
title Marked improvement of Churg–Strauss syndrome neuropathy by intravenous immunoglobulin and cyclophosphamide
title_full Marked improvement of Churg–Strauss syndrome neuropathy by intravenous immunoglobulin and cyclophosphamide
title_fullStr Marked improvement of Churg–Strauss syndrome neuropathy by intravenous immunoglobulin and cyclophosphamide
title_full_unstemmed Marked improvement of Churg–Strauss syndrome neuropathy by intravenous immunoglobulin and cyclophosphamide
title_short Marked improvement of Churg–Strauss syndrome neuropathy by intravenous immunoglobulin and cyclophosphamide
title_sort marked improvement of churg–strauss syndrome neuropathy by intravenous immunoglobulin and cyclophosphamide
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184514/
https://www.ncbi.nlm.nih.gov/pubmed/25473575
http://dx.doi.org/10.1002/rcr2.56
work_keys_str_mv AT umedaakira markedimprovementofchurgstrausssyndromeneuropathybyintravenousimmunoglobulinandcyclophosphamide
AT yamanetateki markedimprovementofchurgstrausssyndromeneuropathybyintravenousimmunoglobulinandcyclophosphamide
AT takeuchijin markedimprovementofchurgstrausssyndromeneuropathybyintravenousimmunoglobulinandcyclophosphamide
AT imaiyasuo markedimprovementofchurgstrausssyndromeneuropathybyintravenousimmunoglobulinandcyclophosphamide
AT suzukikeisuke markedimprovementofchurgstrausssyndromeneuropathybyintravenousimmunoglobulinandcyclophosphamide
AT yumurawako markedimprovementofchurgstrausssyndromeneuropathybyintravenousimmunoglobulinandcyclophosphamide